Travis Jackson

Travis Jackson

Polsinelli

Contact  |  View Bio  |  RSS

Latest Publications

Share:

340B in the Spotlight This Thursday: Congress Offers Webcast of Upcoming Hearing Regarding the 340B Drug Pricing Program

Thursday, March 5th at 10:00 a.m. EST, the House Energy & Commerce Health Subcommittee on Health will hold a hearing entitled, “Examining the 340B Drug Pricing Program.” The purpose of the hearing is to review the...more

3/4/2015 - Health Care Providers Healthcare Pharmaceutical Pharmaceutical Manufacturers Prescription Drugs Section 340B

340B State of Affairs – Study Reveals Benefits to Vulnerable, Chronically Ill Patients

The 340B provider community received welcome news from a recent study published by Health Affairs, which published a long-awaited report analyzing 12 months of outpatient prescription data to identify trends in 340B contract...more

12/3/2014 - 340B HHS HRSA Market Research Pharmaceutical Pharmaceutical Manufacturers Pharmacies Prescription Drugs Proposed Regulation

Breaking 340B News: HRSA Withdrew its Much-Anticipated 340B Mega-Reg

On Thursday, HRSA formally withdrew its much-anticipated 340B Mega-Reg from the rulemaking process, effectively abandoning its effort to overhaul existing 340B program guidance through new regulations. Commander Krista...more

11/18/2014 - HRSA Rulemaking Process Section 340B

Recent 340B Orphan Drug Decision May Have Widespread Implications

In This Issue: - Orphan Drug Rule Background - PhRMA Sues to Block the Orphan Drug Rule - District Court Says HHS Overstepped Its Authority and Invalidates Orphan Drug Rule - Implications on the...more

6/4/2014 - 340B HHS Orphan Drugs Patent Litigation Patents Pharmaceutical Pharmaceutical Patents PHRMA Prescription Drugs

4 Results
|
View per page
Page: of 1